胰岛素泵联合个性化饮食方案治疗妊娠糖尿病的效果评价

Evaluation of Effect of Insulin Pump and Personalized Diet Regimen on Gestational Diabetes

目的对妊娠糖尿病患者应用胰岛素泵联合个性化饮食方案治疗的效果进行探讨。方法方便选取该院2016年8月—2017年9月间收治的94例妊娠糖尿病患者作为研究样本,将其随机分为两组进行实验探讨,实施胰岛素泵联合个性化饮食治疗者设定为观察组,给予单纯胰岛素泵治疗者设定为对照组,每组47例患者,比较两种治疗方式的应用效果。结果血糖控制效果方面,观察组空腹血糖为(4.84±2.03)mmol/L,餐后2 h血糖为(7.21±2.01)mmol/L;对照组空腹血糖为(6.21±2.05)mmol/L,餐后2 h血糖为(8.14±2.03)mmol/L,观察组的血糖水平均低于对照组(t=5.921、7.053,P<0.05)。观察组血糖达标时间为(4.72±1.12)d、胰岛素用量为(39.64±1.25)U/d,对照组血糖达标时间为(7.78±1.16)d、胰岛素用量为(50.12±1.43)U/d,观察组的血糖达标时间和胰岛素用量均优于对照组(t=5.104、11.398,P<0.05)。观察组产妇并发症发生率为6.38%,新生儿并发症发生率为6.38%,对照组产妇并发症发生率为21.27%,新生儿并发症发生率为27.65%,观察组产妇和新生儿的并发症发生率均低于对照组(χ~2=17.214、19.632,P<0.05)。结论临床对妊娠糖尿病患者实施胰岛素联合个性化饮食方案进行治疗,可有效调节血糖水平,保证母婴健康平安,故方案有进一步推广的价值。

Objective This paper tries to explore the effect of insulin pump combined with individualized diet for patients with gestational diabetes. Methods A total of 94 gestational diabetes patients admitted to our hospital from August 2016 to September 2017 were selected conveniently as study samples. They were randomly divided into two groups to conduct an experimental study. The insulin pump combined with personalized dietary treatment was set as the observation group. Patients who received simple insulin pump treatment were assigned to the control group, 47 patients in each group. The effect of the two treatment methods was compared. Results In terms of glycemic control, fasting plasma glucose was（4.84±2.03）mmol/L in the observation group（7.21±2.01）mmol/L in 2 h after meal, and（6.21±2.05）mmol/L in the control group, and 2 h after meal. The blood glucose was（8.14±2.03）mmol/L. The blood glucose level in the observation group was lower than that in the control group（t=5.921, 7.053, P〈0.05）. The observation time of blood glucose in the observation group was（4.72±1.12）days, the dosage of insulin was（39.64±1.25）U/d, the control time of blood glucose in the control group was（7.78±1.16）d,and the dosage of insulin was（50.12±1.43）U/d. The observation time and insulin dose of the observation group were better than those of the control group（t= 5.104, 11.398, P〈0.05）. The incidence of maternal complications in the observation group was 6.38%, the incidence of neonatal complications was 6.38%, the incidence of maternal complications in the control group was 21.27%, and the incidence of neonatal complications was 27.65%. Concurrency of the maternal and neonatal groups in the observation group was lower than that of the control group（χ^2=17.214,19.632, P〈0.05）. Conclusion Clinical treatment of gestational diabetes patients with insulin combined with personalized diet programs can effectively regulate blood glucose levels and ensure maternal and child health and safety, so the program has the value of further promotion.